186
Participants
Start Date
February 14, 2022
Primary Completion Date
November 3, 2022
Study Completion Date
November 3, 2022
Healsea® Children
Children will be administered Healsea Children , one puff (1-2 sec) in each nostril twice a day for 10 days on top of conventional therapies, as needed
Conventional therapies for common cold
Children will receive conventional therapies for common cold, nasal irrigation excluded (antipyretics, mucolytics, decongestants, antitussives, systemic and topical corticosteroids, antibiotics)
Research Site, Bialystok
Research Site, Bialystok
Research Site, Bydgoszcz
Research Site, Dys
Research Site, Głowno
Research Site, Krakow
Research Site, Lublin
Research Site, Lublin
Research Site, Lublin
Research Site, Lublin
Research Site, Lublin
Research Site, Rzeszów
Research Site, Tarnów
Research Site, Warsaw
Research Site, Łomża
Lead Sponsor
Lallemand Pharma AG
INDUSTRY